92
Views
4
CrossRef citations to date
0
Altmetric
Review

Outbreak and Regression of COVID-19 Epidemic Among Chinese Medical Staff

&
Pages 1095-1102 | Published online: 11 Aug 2020

References

  • Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382(13):1199–1207. doi:10.1056/NEJMoa200131631995857
  • Wuhan Municipal Health Commission. Report of viral pneumonia of unknown cause. Available from: http://www.nhc.gov.cn/xcs/yqtb/202001/1beb46f061704372b7ca41ef3e682229.shtml.
  • Chinese National Health Commission. Announcement. Available from: http://www.nhc.gov.cn/xcs/zhengcwj/202001/44a3b8245e8049d2837a4f27529cd386.shtml.
  • Chinese Center for Disease Prevention and Control. Epidemic update and risk assessment of 2019 novel coronavirus. Available from: http://www.chinacdc.cn/yyrdgz/202001/P020200128523354919292.pdf. Accessed 83, 2020.
  • Hui DS, Azhar E, Madani A, et al. The continuing 2019-nCoV epidemic threat of novel coronavirus to global health-the latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis. 2020;91:264–266. doi:10.1016/j.ijid.2020.01.00931953166
  • World Health Organization. Coronavirus disease 2019 (COVID-19) situation report-50; 2020 Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200310-sitrep-50-COVID-19.pdf. Accessed 310, 2020.
  • HubeiProvince Health Commission. Bulletin on novel coronavirus pneumonia. Available from: http://wjw.hubei.gov.cn/bmdt/ztzl/fkxxgzbdgrfyyq/xxfb/202001/t20200121_2013871.shtml.
  • Special Expert Group for Control of the Epidemic of Novel Coronavirus of the Chinese Preventive Medicine Association. An update on the epidemiological characteristics of novel coronavirus pneumonia (COVID-19). Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41(2):139–144. doi:10.3760/cma.j.issn.0254-6450.2020.02.002.32057211
  • Novel Coronavirus Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of2019 novel coronavirus diseases (COVID-19) in China. Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41(2):145–151. doi:10.3760/cma.j.issn.0254-6450.2020.02.003.32064853
  • Jung SM, Akhmetzhanov AR, Hayashi K, et al. Real-time estimation of the risk of death from novel coronavirus (COVID-19) infection: inference using exported cases. J Clin Med. 2020;9(2):523. doi:10.3390/jcm9020523
  • Zu ZY, Jiang MD, Xu PP, et al. Coronavirus disease 2019 (COVID-19): a perspective from China. Radiology. 2020;21:200490. doi:10.1148/radiol.2020200490
  • Wu ZY, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention. JAMA. 2020;2. doi:10.1001/jama.2020.2648.
  • Yu F, Du L, Ojcius D, et al. Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China. Microbes Infect. 2020;22(2):74–79. doi:10.1016/j.micinf.2020.01.00332017984
  • World Health Organization. Laboratory testing for coronavirus disease 2019 (COVID-19) in suspected human cases: interim guidance. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/laboratory-guidance. Accessed 83, 2020.
  • Wu JT, Leung K, Leung GM. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. Lancet. 2020;395(10225):689–697. doi:10.1016/S0140-6736(20)30260-932014114
  • Cohen J, Normile D. New SARS-like virus in China triggers alarm. Science. 2020;367(6475):234–235. doi:10.1126/science.367.6475.23431949058
  • World Health Organization. Protocol for assessment of potential risk factors for 2019-novel coronavirus (2019-nCoV) infection among health care workers in a health care setting; 2020 Available from: https://www.who.int/publications-detail/protocol-for-assessment-of-potential-risk-factors-for-2019-novel-coronavirus-(2019-ncov)-infection-among-health-care-workers-in-a-health-care-setting. Accessed 83, 2020.
  • Zhao S, Lin Q, Ran J, et al. Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: a data-driven analysis in the early phase of the outbreak. Int J Infect Dis. 2020. doi:10.1016/j.ijid.2020.01.050
  • Wang L, Shi Y, Xiao T, et al. Chinese expert consensus on the perinatal and neonatal management for the prevention and control of the 2019 novel coronavirus infection (first edition). Ann Transl Med. 2020;8(3):47. doi:10.21037/atm.2020.02.2032154287
  • Hui DS, Zumla A. Severe acute respiratory syndrome: historical, epidemiologic, and clinical features. Infect Dis Clin North Am. 2019;33(4):869–889. doi:10.1016/j.idc.2019.07.00131668196
  • Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle. J Med Virol. 2020. doi:10.1002/jmv.25678
  • Tang B, Bragazzi NL, Li Q, et al. An updated estimation of the risk of transmission of the novel coronavirus (2019-nCov). Infect Dis Model. 2020;11(5):248–255. doi:10.1016/j.idm.2020.02.001
  • Xu XW, Wu XX, Jiang XG, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 2020:368. doi:10.1136/bmj.m606.
  • Lai CC, Shih TP, Ko WC, et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and corona virus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents. 2020;55(3):105924. doi:10.1101/2020.03.27.2004542732081636
  • Parry J. China coronavirus: cases surge as official admits human to human transmission. BMJ. 2020;368. doi:10.1136/bmj.m236
  • Habibzadeh P, Stoneman EK. The novel coronavirus: a bird’s eye view. Int J Occup Environ Med. 2020;11(2):65–71. doi:10.15171/ijoem.2020.192132020915
  • Riou J, Althaus CL. Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), december 2019 to January 2020. Eurosurveillance. 2020;25(4). doi:10.2807/1560-7917.ES.2020.25.4.2000058
  • Liu T, Hu JX, Kang M, et al. Transmission dynamics of 2019 novel coronavirus (2019-nCoV). bioRxiv. 2020. doi:10.1101/2020.01.25.919787
  • Dai WC, Zhang HW, Yu J, et al. CT imaging and differential diagnosis of COVID-19. Can Assoc Radiol J. 2020:846537120913033. doi:10.1177/0846537120913033.
  • Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475–481. doi:10.1016/S2213-2600(20)30079-532105632
  • Wang DW, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020:e201585. doi:10.1001/jama.2020.1585.
  • Zhao S, Musa SS, Lin Q, et al. Estimating the unreported number of novel coronavirus (2019-nCoV) cases in China in the first half of january 2020: a data-driven modelling analysis of the early outbreak. J Clin Med. 2020;9(2):388. doi:10.3390/jcm9020388
  • Zhou P, Yang XL, Wang XG, et al. Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin. bioRxiv. 2020. doi:10.1101/2020.01.22.914952v1
  • Kruse RL. Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China. F1000Res. 2020;9:72. doi:10.12688/f1000research.22211.232117569
  • Shao P, Shan YJ. Beware of asymptomatic transmission: study on 2019-nCoV prevention and control measures based on extended SEIR model. bioRxiv. 2020;1(28):923169. doi:10.1101/2020.01.28.923169
  • Cheng VC, Wong SC, To KKW, et al. Preparedness and proactive infection control measures against the emerging Wuhan coronavirus pneumonia in China. J Hosp Infect. 2020;104(3):254–255. doi:10.1016/j.jhin.2020.01.01031962139
  • She J, Jiang J, Ye L, et al. 2019 novel coronavirus of pneumonia in Wuhan, China: emerging attack and management strategies. Clin Transl Med. 2020;9(1):19. doi:10.1186/s40169-020-00271-z32078069
  • Yi Y, Lagniton PNP, Ye S, et al. COVID-19: what has been learned and to be learned about the novel coronavirus disease. Int J Biol Sci. 2020;16(10):1753–1766. doi:10.7150/ijbs.4513432226295
  • Xiong CL, Jiang LF, Chen Y, et al. Evolution and variation of 2019-novel coronavirus. bioRxiv. 2020;1(30):926477. doi:10.1101/2020.01.30.926477
  • Xu XT, Chen P, Wang JF. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life Sci. 2020;63(3):457–460. doi:10.1007/s11427-020-1637-532009228
  • Wang H, Wang Z, Dong Y, et al. Phase-adjusted estimation of the number of coronavirus disease 2019 cases in Wuhan, China. Cell Discov. 2020;6(1):10. doi:10.1038/s41421-020-0148-032133152
  • World Health Organization. Statement on the second meeting of the international health regulations (2005) emergency committee regarding the outbreak of novel coronavirus (2019-nCoV). Available from: https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov). Accessed 83, 2020.
  • Chen TM, Rui J, Wang QP, et al. A mathematical model for simulating the transmission of Wuhan novel Coronavirus. bioRxiv. 2020. doi:10.1101/2020.01.23.916395
  • Ming WK, Huang J, Casper J, et al. Breaking down of healthcare system: mathematical modelling for controlling the novel coronavirus (2019-nCoV) outbreak in Wuhan, China. bioRxiv. 2020;1(27):922443. doi:10.1101/2020.01.27.922443
  • Huang LL, Shen SP, Yu P, et al. Dynamic basic reproduction number based evaluation for current prevention and control of COVID-19 outbreak in China. Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41(4):466–469. doi:10.3760/cma.j.cn112338-20200209-0008032113197
  • Tang B, Wang X, Li Q, et al. Estimation of the transmission risk of the 2019-nCoV and its implication for public health interventions. J Clin Med. 2020;9(2):462. doi:10.3390/jcm9020462
  • Wang C, Horby P, Hayden F, et al. A novel coronavirus outbreak of global health concern. Lancet. 2020;395(10223):470–473. doi:10.1016/S0140-6736(20)30185-931986257
  • Shen MW, Peng ZH, Xiao NN, et al. Modelling the epidemic trend of the 2019 novel coronavirus outbreak in China. bioRxiv. 2020;1(23):916726. doi:10.1101/2020.01.23.916726
  • Huang Q, Herrmann A. Fast assessment of human receptor-binding capability of 2019 novel coronavirus (2019-nCoV). bioRxiv. 2020;930537. doi:10.1101/2020.02.01.930537
  • Zhao S, Lin QY, Ran JJ, et al. Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: a data-driven analysis in the early phase of the outbreak. bioRxiv. 2020. doi:10.1101/2020.01.23.916395
  • Wu F, Zhao S, Yu B, et al. Complete genome characterisation of a novel coronavirus associated with severe human respiratory disease in Wuhan, China. bioRxiv. 2020. doi:10.1101/2020.01.24.919183
  • Thompson RN. 2019–20 Wuhan coronavirus outbreak: intense surveillance is vital for preventing sustained transmission in new locations. bioRxiv. 2020. doi:10.1101/2020.01.24.919159
  • Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan China. Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-531986264
  • Li H, Wang YM, Xu JY, et al. Potential antiviral therapeutics for 2019 novel coronavirus. Zhonghua Jie He He Hu Xi Za Zhi. 2020;43(3):170–172. doi:10.3760/cma.j.issn.1001-0939.2020.03.00432164080
  • Zhou H, Wang S, von Seidlein L, et al. The epidemiology of norovirus gastroenteritis in China: disease burden and distribution of genotypes. Front Med. 2020;1(1):1–7. doi:10.1007/s11684-019-0733-5
  • Perlman S. Another decade, another coronavirus. N Engl J Med. 2020;382(8):760–762. doi:10.1056/NEJMe200112631978944
  • Peeri NC, Shrestha N, Rahman MS, et al. The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? Int J Epidemiol. 2020:dyaa033. doi:10.1093/ije/dyaa033.